Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 May 18;160(10):1436–1440.

Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children

U D Allen 1, N MacDonald 1, L Fuite 1, F Chan 1, D Stephens 1
PMCID: PMC1232603  PMID: 10352632

Abstract

BACKGROUND: There are increasing concerns regarding antimicrobial resistance in Canada. Data are limited on the prevalence, patterns of resistance and risk factors associated with resistant organisms, including coliforms, in children. This study was done to address these issues as they relate to urinary tract isolates of Escherichia coli in a tertiary care pediatric centre in Ottawa. METHODS: A surveillance study was conducted from December 1992 to December 1994. Susceptibility testing of urinary tract isolates of E. coli was performed using a panel of antimicrobial agents. A case-control study was also conducted for subjects with isolates resistant to trimethoprim-sulfamethoxazole (T-S), this drug being used a representative "first-line" agent. RESULTS: A total of 1636 consecutive isolates were obtained from 967 subjects. Of the 1636 isolates, 736 (45.0%) were resistant to ampicillin, 514 (31.4%) were resistant to T-S, 363 (22.2%) were resistant to both ampicillin and T-S, and 27 (1.7%) were resistant to both ampicillin and gentamicin. In the case-control study 274 children with isolates resistant to T-S were matched with 274 children who had T-S-sensitive isolates obtained during the study period or the preceding or subsequent 6 months. Multivariate analyses indicated that subjects who had received antimicrobials for more than 4 weeks in the previous 6 months were about 23 times more likely to have isolates resistant to T-S than were subjects without this risk factor (odds ratio [OR] 23.4, 95% confidence interval [CI] 12.0-47.6). Children with genitourinary tract abnormalities were 2.4 times more likely to have resistant isolates than those without such abnormalities (95% CI 1.2-4.5). Compared with children who had no hospital admissions in the previous year, those with 1 admission in that period were more likely to have resistant isolates (OR 2.3, 95% CI 1.4-7.5), as were those with 2 or more admissions in that period (OR 3.2, 95% CI 1.1-4.8). Compared with children aged 2-6 years, children under 2 years of age were less likely to have resistant isolates (OR 0.3, 95% CI 0.2-0.8). INTERPRETATION: Selective antimicrobial pressure and multiple admissions to hospital were among the risk factors associated with antimicrobial resistance. The finding of a low but definite level of resistance to both ampicillin and gentamicin is important for the selection of empiric therapy for sepsis in neonates. The role of inexpensive first-line agents in the outpatient treatment and prevention of urinary tract infections requires re-examination, particularly in children who have recently received antimicrobial therapy.

Full Text

The Full Text of this article is available as a PDF (130.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Edmond M. B., Ober J. F., Weinbaum D. L., Pfaller M. A., Hwang T., Sanford M. D., Wenzel R. P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995 May;20(5):1126–1133. doi: 10.1093/clinids/20.5.1126. [DOI] [PubMed] [Google Scholar]
  3. Gribble M. J., Puterman M. L. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med. 1993 Aug;95(2):141–152. doi: 10.1016/0002-9343(93)90254-m. [DOI] [PubMed] [Google Scholar]
  4. Landis J. R., Koch G. G. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159–174. [PubMed] [Google Scholar]
  5. McCracken G. H., Jr Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J. 1995 May;14(5):424–428. doi: 10.1097/00006454-199505001-00004. [DOI] [PubMed] [Google Scholar]
  6. McGowan J. E., Jr Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983 Nov-Dec;5(6):1033–1048. doi: 10.1093/clinids/5.6.1033. [DOI] [PubMed] [Google Scholar]
  7. Murray B. E., Alvarado T., Kim K. H., Vorachit M., Jayanetra P., Levine M. M., Prenzel I., Fling M., Elwell L., McCracken G. H. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis. 1985 Dec;152(6):1107–1113. doi: 10.1093/infdis/152.6.1107. [DOI] [PubMed] [Google Scholar]
  8. Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. doi: 10.1056/NEJM198201213060302. [DOI] [PubMed] [Google Scholar]
  9. Murray B. E. What can we do about vancomycin-resistant enterococci? Clin Infect Dis. 1995 May;20(5):1134–1136. doi: 10.1093/clinids/20.5.1134. [DOI] [PubMed] [Google Scholar]
  10. Reves R. R., Fong M., Pickering L. K., Bartlett A., 3rd, Alvarez M., Murray B. E. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob Agents Chemother. 1990 Jul;34(7):1429–1434. doi: 10.1128/aac.34.7.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schaad U. B. Role of the new quinolones in pediatric practice. Pediatr Infect Dis J. 1992 Dec;11(12):1043–1046. doi: 10.1097/00006454-199211120-00010. [DOI] [PubMed] [Google Scholar]
  12. Seppälä H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenius H., Lager K., Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997 Aug 14;337(7):441–446. doi: 10.1056/NEJM199708143370701. [DOI] [PubMed] [Google Scholar]
  13. Singh M., Chaudhry M. A., Yadava J. N., Sanyal S. C. The spectrum of antibiotic resistance in human and veterinary isolates of Escherichia coli collected from 1984-86 in northern India. J Antimicrob Chemother. 1992 Feb;29(2):159–168. doi: 10.1093/jac/29.2.159. [DOI] [PubMed] [Google Scholar]
  14. Smith E. M., Elder J. S. Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections. Urology. 1994 May;43(5):708–713. doi: 10.1016/0090-4295(94)90190-2. [DOI] [PubMed] [Google Scholar]
  15. Swartz M. N. Use of antimicrobial agents and drug resistance. N Engl J Med. 1997 Aug 14;337(7):491–492. doi: 10.1056/NEJM199708143370709. [DOI] [PubMed] [Google Scholar]
  16. Tan T. Q., Mason E. O., Jr, Kaplan S. L. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec;92(6):761–767. [PubMed] [Google Scholar]
  17. Wald E. R., Dashefsky B., Byers C., Guerra N., Taylor F. Frequency and severity of infections in day care. J Pediatr. 1988 Apr;112(4):540–546. doi: 10.1016/s0022-3476(88)80164-1. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES